Alpha 2.0
Login Register
» Articles » PMID: 26827761

Intrathecal Minocycline Suppresses Itch-Related Behavior and Improves Dermatitis in a Mouse Model of Atopic Dermatitis

Overview
Journal J Invest Dermatol
Publisher Elsevier
Specialty Dermatology
Date 2016 Feb 2
PMID 26827761
Citations 8
Authors
Kei Torigoe
Mitsutoshi Tominaga
Kyi Chan Ko
Nobuaki Takahashi
Hironori Matsuda
Ryuichi Hayashi
Hideoki Ogawa
Kenji Takamori
Affiliations
Soon will be listed here.
Citing Articles

Tetracyclines Revisited: Tetracyclines in the Field of Dermatology.

Kim Y, Kim H Dermatology. 2024; 240(5-6):844-858.

PMID: 39427643 PMC: 11651335. DOI: 10.1159/000542006.

Treatment Options for Troublesome Itch.

Toyama S, Tominaga M, Takamori K Pharmaceuticals (Basel). 2022; 15(8).

PMID: 36015170 PMC: 9412524. DOI: 10.3390/ph15081022.

Acupuncture for the Treatment of Itch: Peripheral and Central Mechanisms.

Tang Y, Cheng S, Wang J, Jin Y, Yang H, Lin Q Front Neurosci. 2022; 15:786892.

PMID: 35431769 PMC: 9005788. DOI: 10.3389/fnins.2021.786892.

Microglia-mediated chronic psoriatic itch induced by imiquimod.

Xu Z, Qin Z, Zhang J, Wang Y Mol Pain. 2020; 16:1744806920934998.

PMID: 32580615 PMC: 7318815. DOI: 10.1177/1744806920934998.

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer.

Sano K, Nakadate K, Hanada K BMC Cancer. 2020; 20(1):279.

PMID: 32252690 PMC: 7137492. DOI: 10.1186/s12885-020-06797-2.